Amarin Supports Trial to Investigate the Effects of VASCEPA® (icosapent ethyl) in the Treatment of COVID-19

NASDAQ Market News

NEXT STORY
ContraFect Corporation Announces Proposed Public Offering of Common Stock and Warrants
PREV STORY
Geron Announces Plans for Imetelstat Phase 3 Clinical Trial in Myelofibrosis and Other Updates
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Calithera Biosciences to Host R&D Day and Webcast on October 5, 2018

SOUTH SAN FRANCISCO, Calif., Sept. 26, 2018 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: ...

author_avatar
NASDAQ Market News

Galena Biopharma Announces Pricing of Public Offering of Common Stock and Warrants

SAN RAMON, Calif., Jan. 07, 2016 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE), a ...

author_avatar
NASDAQ Market News

CURE Pharmaceutical Welcomes Researcher and Innovator in Pediatric Medicine Michael Neely to Advisory Board

OXNARD, Calif., March 23, 2017 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTCQB:CURR), (“CURE”) or (the ...

author_avatar
NASDAQ Market News